SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-075412
Filing Date
2014-10-31
Accepted
2014-10-31 07:56:26
Documents
9
Period of Report
2014-10-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-23408_18k.htm 8-K 25109
2 EX-99.1 a14-23408_1ex99d1.htm EX-99.1 543724
3 GRAPHIC g234081mm03i001.jpg GRAPHIC 1814
4 GRAPHIC g234081mm13i001.jpg GRAPHIC 1814
5 GRAPHIC g234081mm11i001.jpg GRAPHIC 1786
6 GRAPHIC g234081mm05i001.jpg GRAPHIC 1814
7 GRAPHIC g234081mm01i001.jpg GRAPHIC 1814
8 GRAPHIC g234081mm09i001.jpg GRAPHIC 1786
9 GRAPHIC g234081mm07i001.jpg GRAPHIC 1814
  Complete submission text file 0001104659-14-075412.txt   588426
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 141184834
SIC: 2834 Pharmaceutical Preparations